6 September 2017 (Wednesday) - Transfusion News e-newsletter

The Transfusion News e-newsletter arrived in my in-box this morning as well. Perhaps because It is less generalist and more discipline-specific I find it not only more relevant than the IBMS newsletter which arrived seconds earlier, but I find myself more inclined to actually look at it…

Rather an important thing with any learning tool…

Leukoreduction of Platelet Units Followed by Mirasol Pathogen Reduction May Prevent Alloimmunization August 30, 2017 Alloimmunization to donor platelets is common in transfused, immunosuppressed oncology patients. Leukoreduction reduces alloimmunization by more than half. Researchers recently investigated different methods to further reduce alloimmunization after platelet transfusion including leukoreduction with different filters, γ-irradation and Mirasol pathogen reduction using a dog transfusion model. Using a highly immunogenic model, most donor/recipient dog pairs were [Read More] Intravenous Immunoglobulin Treatment for Patients with Heparin-Induced Thrombocytopenia Patients Unresponsive to Standard Treatment August 23, 2017 Heparin-induced thrombocytopenia (HIT) is a severe complication of heparin treatment with significant risks of morbidity and mortality. HIT is caused by platelet-activating antibodies against complexes of platelet factor 4 and heparin. Although HIT patients have low levels of platelets, the risk of thrombosis is high and the use of other anticoagulants may increase the risk [Read More] Hemolytic Disease of the Newborn with Greg Denomme September 5, 2017 | BBGuy Podcast Hemolytic Disease of the Fetus and Newborn (HDFN) is not just a diagnosis from the history books! It still happens, and all involved must respond quickly. Dr. Greg Denomme guides us to better HDFN understanding and management.